The EU's drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.
Novavax's jab, a protein-based vaccine of the kind used around the world to protect against many childhood illnesses, would be the fifth coronavirus shot authorised for the European Union.The European Medicines Agency said its human medicines committee would hold an extraordinary meeting to decide on Novavax on Monday, and "will communicate the outcome".
All vaccines work by teaching the body's immune system to attack the coronavirus, but they do it in different ways. When injected, these trigger a reaction by the immune system, so that if it later comes into contact with the Covid virus, it knows to attack it. Rare but serious side effects of heart inflammation have been reported with the mRNA vaccines, and blood clots with the viral vector vaccines.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
UK Foreign Secretary Truss to take over Brexit talks with EUForeign Secretary Liz Truss will become Britain's lead negotiator with the European Union over the Northern Ireland Protocol following the resignation of Brexit minister David Frost, Prime Minister Boris Johnson's office said on Sunday.
Consulte Mais informação »
103 Marines booted for refusing COVID vaccine as services begin dischargesThe Marines have discharged more than 100 Marines for refusing to take the COVID vaccine.
Consulte Mais informação »
CDC Panel Backs mRNA COVID Vaccines Over J&J Due to Clot RiskThe CDC panel voted unanimously to prefer the Pfizer and Moderna vaccines after hearing a safety update on cases of thrombosis with thrombocytopenia syndrome, a condition that causes large clots that deplete the blood of platelets, resulting in uncontrolled bleeding.
Consulte Mais informação »
Pfizer to Push Back Its COVID-19 Vaccine for Babies and ToddlersRead about a statement from Pfizer and BioNTech, in which they explain they will now be testing a three-dose COVID-19 vaccine for the youngest age group of babies and toddlers.
Consulte Mais informação »
What's the timeline for kids under 5 to get a COVID vaccine?Pfizer reports that a lower dose of its COVID-19 vaccine did not produce a potent immune response in children 2 to 4. Here's what we know.
Consulte Mais informação »
In setback, Pfizer tests three doses of COVID vaccine for children under 5Pfizer is testing an extra dose of its COVID-19 vaccine for babies and preschoolers after preliminary research hinted the usual two doses wouldn't be enough.
Consulte Mais informação »